These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 465731)

  • 1. ABO compatibility and platelet transfusions of alloimmunized thrombocytopenic patients.
    Duguesnoy RJ; Anderson AJ; Tomasulo PA; Aster RH
    Blood; 1979 Sep; 54(3):595-9. PubMed ID: 465731
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Successful transfusion of platelets "mismatched" for HLA antigens to alloimmunized thrombocytopenic patients.
    Duquesnoy RJ; Filip DJ; Rodey GE; Rimm AA; Aster RH
    Am J Hematol; 1977; 2(3):219-26. PubMed ID: 596366
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ABO compatibility can influence the results of platelet transfusion. Results of a randomized trial.
    Lee EJ; Schiffer CA
    Transfusion; 1989 Jun; 29(5):384-9. PubMed ID: 2660333
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of HLA-A2 on the effectiveness of platelet transfusions in alloimmunized thrombocytopenic patients.
    Duquesnoy RJ; Filip DJ; Aster RH
    Blood; 1977 Sep; 50(3):407-12. PubMed ID: 884318
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of HLA Bw4/Bw6 compatibility on platelet transfusion responses of refractory thrombocytopenic patients.
    McElligott MC; Menitove JE; Duquesnoy RJ; Hunter JB; Aster RH
    Blood; 1982 May; 59(5):971-5. PubMed ID: 6951616
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A flow cytometric platelet immunofluorescence crossmatch for predicting successful HLA matched platelet transfusions.
    Sintnicolaas K; Löwenberg B
    Br J Haematol; 1996 Mar; 92(4):1005-10. PubMed ID: 8616059
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Platelet crossmatching. A direct approach to the selection of platelet transfusions for the alloimmunized thrombocytopenic patient.
    Kickler TS; Ness PM; Braine HG
    Am J Clin Pathol; 1988 Jul; 90(1):69-72. PubMed ID: 3389345
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Donor selection in platelet transfusion therapy of alloimmunized thrombocytopenic patients.
    Duqesnoy RJ
    Prog Clin Biol Res; 1978; 28():229-43. PubMed ID: 88057
    [No Abstract]   [Full Text] [Related]  

  • 9. Transfusion strategy: use of HLA-matched platelet transfusions for alloimmunized patients.
    Menitove JE; Duquesnoy RJ
    Am J Med Technol; 1981 Feb; 47(2):114-20. PubMed ID: 7223758
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Factors that influence platelet recovery after transfusion: resolving donor quality from ABO compatibility.
    Jiménez TM; Patel SB; Pineda AA; Tefferi A; Owen WG
    Transfusion; 2003 Mar; 43(3):328-34. PubMed ID: 12675717
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An evaluation of crossmatching, HLA, and ABO matching for platelet transfusions to refractory patients.
    Heal JM; Blumberg N; Masel D
    Blood; 1987 Jul; 70(1):23-30. PubMed ID: 3474041
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A prospective randomized trial of HLA-matched versus mismatched single-donor platelet transfusions in cancer patients.
    Messerschmidt GL; Makuch R; Appelbaum F; Ungerleider RS; Abrams R; O'Donnell J; Holohan TV; Fontana J; Wright D; Anagnou NP
    Cancer; 1988 Aug; 62(4):795-801. PubMed ID: 3293762
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ABO-mismatched platelet transfusions: strategies to mitigate patient exposure to naturally occurring hemolytic antibodies.
    Josephson CD; Castillejo MI; Grima K; Hillyer CD
    Transfus Apher Sci; 2010 Feb; 42(1):83-8. PubMed ID: 20034854
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of HLA-C matching in histocompatible platelet transfusion therapy of alloimmunized thrombocytopenic patients.
    Duquesnoy RJ; Filip DJ; Tomasulo PA; Aster RH
    Transplant Proc; 1977 Dec; 9(4):1827-8. PubMed ID: 601843
    [No Abstract]   [Full Text] [Related]  

  • 15. HLAMatchmaker is effective for selecting appropriate platelet units for alloimmunised thrombocytopaenic patients who are refractory to random donor platelets.
    O'Rafferty C; Rooney G; Hagan R; Woolfson M; O'Donghaile D; Fitzgerald J
    Transfus Med; 2017 Oct; 27 Suppl 5():369-374. PubMed ID: 28393455
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HLAMatchmaker-driven analysis of responses to HLA-typed platelet transfusions in alloimmunized thrombocytopenic patients.
    Nambiar A; Duquesnoy RJ; Adams S; Zhao Y; Oblitas J; Leitman S; Stroncek D; Marincola F
    Blood; 2006 Feb; 107(4):1680-7. PubMed ID: 16269623
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of in vitro assays in selection of compatible platelet donors.
    Tosato G; Appelbaum FR; Trapani RJ; Dowling R; Deisseroth AB
    Transfusion; 1980; 20(1):47-54. PubMed ID: 7355471
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selection of histocompatible apheresis platelet donors by cross-matching random donor platelet concentrates.
    O'Connell BA; Lee EJ; Rothko K; Hussein MA; Schiffer CA
    Blood; 1992 Jan; 79(2):527-31. PubMed ID: 1730095
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute Intravascular Hemolysis Following an ABO Non-Identical Platelet Transfusion: A Case Report and Literature Review.
    Moinuddin IA; Millward P; Fletcher CH
    Am J Case Rep; 2019 Jul; 20():1075-1079. PubMed ID: 31332158
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Statewide support of thrombocytopenic patients with ABO matched single donor platelets.
    Reiss RF; Katz AJ
    Transfusion; 1976; 16(4):312-20. PubMed ID: 951726
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.